Advancing CAR T-cell Therapies with Artificial Intelligence: Opportunities and Challenges

Area of Science:

• Immunotherapy
• Computational Biology
• Biotechnology

Background:

• Chimeric antigen receptor T-cell (CAR T) therapy shows promise in cancer treatment.
• Significant challenges remain in optimizing CAR T therapy efficacy and accessibility.
• Artificial intelligence (AI) presents a transformative opportunity to address these challenges.

Purpose of the Study:

• To explore the potential of AI in enhancing all aspects of CAR T-cell therapy.
• To identify key steps and requirements for integrating AI into CAR T-cell therapy workflows.
• To highlight critical barriers hindering AI implementation and propose solutions.

Main Methods:

• Review of current AI applications in biological and medical research.
• Analysis of the CAR T-cell therapy pipeline from target identification to clinical decision-making.
• Identification of data requirements and challenges for AI model training.

Main Results:

• AI can optimize target identification, vector design, and manufacturing processes.
• AI enables personalized, data-driven clinical decisions for improved patient outcomes.
• Addressing data heterogeneity and patient privacy are essential for AI advancement.

Conclusions:

• AI integration holds significant potential to revolutionize CAR T-cell therapy.
• The development of standardized, comprehensive data repositories is a critical next step.
• Overcoming data-related barriers will unlock AI's full potential in immunotherapy.